Cargando…

Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design

African horse sickness (AHS) is a devastating disease caused by African horse sickness virus (AHSV) and transmitted by arthropods between its equine hosts. AHSV is endemic in sub-Saharan Africa, where polyvalent live attenuated vaccine is in use even though it is associated with safety risks. This r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calvo-Pinilla, Eva, Marín-López, Alejandro, Utrilla-Trigo, Sergio, Jiménez-Cabello, Luís, Ortego, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351391/ https://www.ncbi.nlm.nih.gov/pubmed/32659516 http://dx.doi.org/10.1016/j.coviro.2020.06.003

Ejemplares similares

Viral Vector Vaccines against Bluetongue Virus
por: Jiménez-Cabello, Luis, et al.
Publicado: (2020)

Epizootic Hemorrhagic Disease Virus: Current Knowledge and Emerging Perspectives
por: Jiménez-Cabello, Luis, et al.
Publicado: (2023)

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
por: Aksular, Mine, et al.
Publicado: (2018)

Inhibition of Orbivirus Replication by Aurintricarboxylic Acid
por: Alonso, Celia, et al.
Publicado: (2020)

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus
por: de la Poza, Francisco, et al.
Publicado: (2013)

Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus
por: Utrilla-Trigo, Sergio, et al.
Publicado: (2020)

A protective bivalent vaccine against Rift Valley fever and bluetongue
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor
por: Marín-Lopez, Alejandro, et al.
Publicado: (2019)

The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS2(1-180)) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge
por: Utrilla-Trigo, Sergio, et al.
Publicado: (2022)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
por: Calvo-Pinilla, Eva, et al.
Publicado: (2018)

Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance
por: Jiménez-Cabello, Luis, et al.
Publicado: (2022)

Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge
por: Calvo-Pinilla, Eva, et al.
Publicado: (2015)

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model
por: Castillo-Olivares, Javier, et al.
Publicado: (2011)

Adaptive strategies of African horse sickness virus to facilitate vector transmission
por: Wilson, Anthony, et al.
Publicado: (2009)

Immune response of horses to inactivated African horse sickness vaccines
por: Rodríguez, Marina, et al.
Publicado: (2020)

African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination
por: Castillo‐Olivares, Javier
Publicado: (2020)

Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4
por: Marín-López, Alejandro, et al.
Publicado: (2016)

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
por: Alberca, Berta, et al.
Publicado: (2014)

Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus
por: Calvo-Pinilla, Eva, et al.
Publicado: (2012)

CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR(−/−) Mice
por: Marín-López, Alejandro, et al.
Publicado: (2018)

Pathological features of African horse sickness virus infection in IFNAR(−/−) mice
por: Jones, Luke M., et al.
Publicado: (2023)

Evidence of Intragenic Recombination in African Horse Sickness Virus
por: Ngoveni, Harry G., et al.
Publicado: (2019)

African Horse Sickness Virus Serotype 1 on Horse Farm, Thailand, 2020
por: Bunpapong, Napawan, et al.
Publicado: (2021)

Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine
por: Chaiyabutr, Narongsak, et al.
Publicado: (2022)

Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV)
por: van Rijn, Piet A., et al.
Publicado: (2016)

Establishment of different plasmid only-based reverse genetics systems for the recovery of African horse sickness virus
por: Conradie, Andelé M., et al.
Publicado: (2016)

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
por: Lorenzo, María M., et al.
Publicado: (2023)

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
por: Dennis, Susan J., et al.
Publicado: (2018)

A review of African horse sickness and its implications for Ireland
por: Thompson, Geoffrey M, et al.
Publicado: (2012)

Seroprevalence of African horse sickness in selected donkey populations in Namibia
por: Molini, Umberto, et al.
Publicado: (2020)

Addressing the recent outbreak of African horse sickness in Lagos, Nigeria
por: Adesola, Ridwan Olamilekan, et al.
Publicado: (2023)

Horse Sickness
por: Smith, W. Ramsey
Publicado: (1902)

Quantitative Risk Assessment for African Horse Sickness in Live Horses Exported from South Africa
por: Sergeant, Evan S., et al.
Publicado: (2016)

Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
por: Durán-Ferrer, Manuel, et al.
Publicado: (2022)

Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes
por: Lulla, Valeria, et al.
Publicado: (2016)

Transmission and Control of African Horse Sickness in The Netherlands: A Model Analysis
por: Backer, Jantien A., et al.
Publicado: (2011)

Re-emergence of bluetongue, African horse sickness, and other Orbivirus diseases
por: MacLachlan, N. James, et al.
Publicado: (2010)

African Horse Sickness: A Review of Current Understanding and Vaccine Development
por: Dennis, Susan J, et al.
Publicado: (2019)

Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus
por: Bachanek-Bankowska, Katarzyna, et al.
Publicado: (2014)

Sero-epidemioloical survey on African horse sickness virus among horses in Khartoum State, Central Sudan
por: Karamalla, Siham T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8vcj3ld5akql7pkai7ess4h4f1